| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000025214 |
| Receipt No. | R000029002 |
| Official scientific title of the study | Effects of the nutritional supplementation in combination with exercise therapy for hemodialysis patients complicated with sarcopenia: a randomized parallel-group pilot study |
| Date of disclosure of the study information | 2016/12/10 |
| Last modified on | 2017/11/30 (Ver. 4) |
| Basic information | ||
| Official scientific title of the study | Effects of the nutritional supplementation in combination with exercise therapy for hemodialysis patients complicated with sarcopenia: a randomized parallel-group pilot study | |
| Title of the study (Brief title) | Effects of the nutritional supplementation in combination with exercise therapy for hemodialysis patients complicated with sarcopenia | |
| Region |
|
|
| Condition | |||
| Condition | Hemodialysis patients complicated with sarcopenia | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | To compare the effect of exercise plus nutritional supplementation with that of exercise alone on body composition, muscle function and nutritional status in sarcopenic patients receiving hemodialysis |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | An amount change of the fat free mass |
| Key secondary outcomes | 1. the value change of the skeletal muscle index, lower limb muscle mass, skeletal muscle mass, body cell mass, phase angle and body fat percentage
2. the amount change of the grip strength and knee extension strength 3. the value change of Short Physical Performance Battery(SPPB) 4. the value change of the Geriatric Nutrition Risk Index(GNRI) and Malnutrition-Inflammation Score(MIS) 5. the variation change in the biochemical parameters 6. the value change of the single-pool Kt/Vurea, normalized protein catabolic rate(nPCR) and the creatinine generation rate % (%CGR) 7. the incidence ratio of adverse events |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Open -no one is blinded |
| Control | Active |
| Stratification | NO |
| Dynamic allocation | NO |
| Institution consideration | Institution is not considered as adjustment factor. |
| Blocking | NO |
| Concealment | No need to know |
| Intervention | |||
| No. of arms | 2 | ||
| Purpose of intervention | Treatment | ||
| Type of intervention |
|
||
| Interventions/Control_1 | Exercise therapy with combination of nutritional supplementation: Dietary supplements such as energy of 276kcal, protein of 6.3g, branched-chain amino acid of 1.54g are taken in each day for 12 weeks with the exercise therapy of intervention 2. | ||
| Interventions/Control_2 | Exercise therapy: At the first half of hemodialysis which conducted three times a week, A resistance exercise for 20 to 30 minutes in each time, the level is from mild to moderate as the subjective exercise intensity(11 to 13 in Borg index) is worked out for 12 weeks. | ||
| Interventions/Control_3 | |||
| Interventions/Control_4 | |||
| Interventions/Control_5 | |||
| Interventions/Control_6 | |||
| Interventions/Control_7 | |||
| Interventions/Control_8 | |||
| Interventions/Control_9 | |||
| Interventions/Control_10 | |||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Subjects were enrolled after meeting all the following criteria.
1. Patients have undergone hemodialysis or hemodiafiltration three times a week for more than three months 2. Out-patients 3. Patients, 18 years age or older at the time of submitting written informed consent 4. Patients, after receiving a sufficient explanation upon participation in this study, agreed the consent document in full understanding and with a free will were enrolled as a subject 5. Patients who were diagnosed sarcopenia and pre-sarcopenia in the standard of Asian Working Group for sarcopenia(AWGS) |
|||
| Key exclusion criteria | Persons, met any of the following criteria were excluded.
1. Patients not ensured of an adequate dialysis(below 1.2 in single-pool Kt/Vurea) 2. Patients with cardiovascular disease such as heart failure likely worsening within one week, unstable angina pectoris, myocardial ischemia induced with a low threshold value by slow walking on the level ground(2METS), a candidate for surgery of severe valvular disease, and exercise-induced arrhythmias 3. Patients with an acute systemic disease or fever 4. Patients with complicated severe hypertension, over 180mmHg systolic blood pressure or 100mmHg in diastolic blood pressure 5. Patients having complications with type 1 diabetes, poorly controlled type 2 diabetes and diabetic retinopathy 6. Patients having complication with severe liver disease 7. Patients having an allergy to milk and soy 8. Patients having complication with mental illness causing a communication difficulty 9. patients having a cardiac pacemaker implantation 10. Patients having a history of hospitalization less than one month before the enrollment 11. Additionally, patients, whose principal researcher determined unfit as a subject for the study |
|||
| Target sample size | 15 | |||
| Research contact person | |
| Name of lead principal investigator | Yasunori Suzuki |
| Organization | Kyoto Katsura Hospital |
| Division name | Department of Nephrology |
| Address | 17 Yamadahirao-cho, Nishikyo-ku, Kyoto, 615-8256, Japan |
| TEL | 075-391-5811 |
| yasunori-suzuki@katsura.com | |
| Public contact | |
| Name of contact person | Yasunori Suzuki |
| Organization | Kyoto Katsura Hospital |
| Division name | Dialysis Center |
| Address | 17 Yamadahirao-cho, Nishikyo-ku, Kyoto, 615-8256, Japan |
| TEL | 075-391-5811 |
| Homepage URL | |
| yasunori-suzuki@katsura.com | |
| Sponsor | |
| Institute | Department of Nephrology, Kyoto Katsura Hospital
|
| Institute | |
| Department | |
| Funding Source | |
| Organization | None |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Published |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000029002 |